• UK
  • World
    • USA
  • Entertainment
    • Celeb
    • Showbiz
    • Magazine
  • Politics
  • Sports
  • Gaming
  • Tech
  • Science
    • Education
  • Insurance
  • Business
  • Auto
  • ToS/Contact
    • ToS
    • Privacy Policy
    • Contact
NewsExplored
  • UK
  • World
    • USA
  • Entertainment
    • Celeb
    • Showbiz
    • Magazine
  • Politics
  • Sports
  • Gaming
  • Tech
  • Science
    • Education
  • Insurance
  • Business
  • Auto
  • ToS/Contact
    • ToS
    • Privacy Policy
    • Contact
  • Facebook

  • Twitter

  • LinkedIn

  • Tumblr

  • RSS

UK

Life-extending lung cancer drug approved

Life-extending lung cancer drug approved
Newsexplored
20th September 2017
ShareTweet
SubscribeRedditGoogleWhatsappStumbleuponPinterestDiggLinkedinTumblrTelegram
Views:
13
Writer AA GillImage copyright Getty Images

A life-extending lung cancer drug will be made immediately available to NHS patients in England, say advisers.

Campaigners, including the late Sunday Times restaurant critic AA Gill, have repeatedly called for access to the pioneering immunotherapy, which can add months to life.

Scotland already offers nivolumab to people with advanced disease who have also tried chemotherapy.

England’s drugs watchdog had originally said nivolumab was too expensive.

More life

In new draft guidance, the National Institute for Health and Care Excellence (NICE) has approved nivolumab through the fast-track Cancer Drugs Fund while more evidence is gathered on its cost-effectiveness.

That means some patients – about 1,300 people with advanced squamous and non-squamous non-small cell lung cancer (whose tumours express a molecule called PD-L1) – will now be eligible for the drug.

During his final weeks living with terminal cancer, AA Gill described nivolumab as “more life spent on Earth – but only if you can pay”.

Image copyright Getty Images
Image caption AA Gill, pictured with his partner of 23 years Nicola Formby

The former smoker was diagnosed with lung cancer that had spread to his neck and pancreas, with tumours that were inoperable and unsuitable for radiotherapy.

Gill said he had been denied a drug – costing about £5,000 a month – that may have helped him live “considerably” longer and was the weapon of choice for “every oncologist in the First World”.


What is Nivolumab?

Nivolumab (brand name Opdivo) is a type of immunotherapy that stimulates the body’s immune system to fight cancer cells.

It works by interrupting the chemical signals that cancers use to convince the immune system they are healthy tissue.

data-ad-format="auto">

Patients can have nivolumab into a vein as a drip.

It is used to treat advanced melanoma, blood cancer (Hodgkin lymphoma), kidney cancer and the most common type of lung cancer – non small-cell lung cancer.

It is also used in clinical trials for other types of cancer.


Prof Carole Longson, from NICE, said: “We know that nivolumab is clinically effective for some people with lung cancer, but the full extent of its benefit is not clear.


“This new deal means that we can give patients access to what we know is a promising treatment whilst more evidence is gathered on its value.”

Prof Paul Workman, from the Institute of Cancer Research, in London, said: “Immunotherapies are currently very expensive, but one of the ways to make them more cost-effective is to direct them to patients most likely to respond. Today’s decision is a welcome step in the right direction.”

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Google+ (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Share on Skype (Opens in new window)

Related

Related Itemsapprovedcancerextending
UK
20th September 2017
Newsexplored @newsexploredweb

Related Itemsapprovedcancerextending

More in UK

  • Read More
    Alesha MacPhail murder trial: Boy, 16, denies killing six-year-old girl

    Views:13 Image caption Alesha MacPhail was holidaying on the Isle of Bute where her body was found...

    Newsexplored 20th September 2017
  • Read More
    Alesha MacPhail murder trial: DNA found on body ‘matched accused’

    Views:13 DNA was found on Alesha MacPhail’s body which matched the 16-year-old accused of her murder, a...

    Newsexplored 20th September 2017
  • Read More
    Lauri Love: Alleged hacker loses legal fight over seized PCs

    Views:13 Image caption Lauri Love outside court ahead of a previous hearing An alleged hacker whose computers...

    Newsexplored 20th September 2017
  • Read More
    Labour resignations: John McDonnell promises ‘listening exercise’

    Views:13 Media playback is unsupported on your device Media captionJohn McDonnell: “We need a mammoth listening exercise”...

    Newsexplored 20th September 2017
  • Read More
    Rail customers ‘unable to collect pre-paid tickets’

    Views:13 Image copyright Getty Images Several rail firms are reporting problems with pre-paid ticket collection from machines...

    Newsexplored 20th September 2017
  • Read More
    Euston stabbing: Eleven held after man dies in hotel reception

    Views:13 Image caption The victim had been stabbed multiple times before he entered the hotel in Euston...

    Newsexplored 20th September 2017
  • Read More
    Honda confirms Swindon car plant closure

    Views:13 Image copyright Getty Images Honda has confirmed it will close its Swindon car plant in 2021,...

    Newsexplored 20th September 2017
  • Read More
    Sepsis: New rapid test ‘could save thousands of lives’

    Views:13 Image copyright University of Strathclyde Image caption A close-up of the test device A new rapid...

    Newsexplored 20th September 2017
  • Read More
    UK and French tourists missing in Australia beach search

    Views:13 Image copyright NSW POLICE Image caption Hugo Palmer (left) and Erwan Ferrieux are missing, Australian police...

    Newsexplored 20th September 2017
  • Read More
    Labour warned more MPs ‘thinking hard’ about futures

    Views:13 Media playback is unsupported on your device Media captionMPs resign from Labour over Brexit and anti-Semitism...

    Newsexplored 20th September 2017
  • Read More
    Premature baby born in Vietnam arrives home in Wales

    Views:13 Image caption Aurelia is out of hospital but will still need treatment A couple whose baby...

    Newsexplored 20th September 2017
  • Read More
    Fast fashion: ‘Penny on a garment’ to drive clothes recycling

    Views:13 Image copyright Getty Images Image caption MPs want to see more sustainable designs and repair services...

    Newsexplored 20th September 2017
Scroll for more
Tap
data-ad-format="auto">
NewsExplored

NewsExplored - Making sure all the latest news is explored?

Contact us for help

  • Popular

  • Latest

  • Comments

  • Proxy voting: MPs to trial scheme for pregnant women and new parents
    UK22nd January 2019
  • Prince William says celebrities shunned mental health charity
    UK23rd January 2019
  • Migrants force-fed at Texas detention centre
    USA31st January 2019
  • Antibiotic resistance plan to fight ‘urgent’ global threat
    UK24th January 2019
  • House launches probe of US nuclear plan in Saudi Arabia
    USA19th February 2019
  • Bernie Sanders announces second US presidential bid
    USA19th February 2019
  • SeaWorld rescue: Firefighters rescue 16 people from San Diego ride
    USA19th February 2019
  • Ex-Russia probe overseer Rod Rosenstein ‘to step down by March’
    USA19th February 2019
  • Les Rehrer says:

    Hello Its me :P and thanks for this post

  • optumrx login says:

    Thank For News.

  • Kent Laatsch says:

    Please let me know if you're looking for a writer…

  • Bob says:

    RT News was where I learned that Erdogan controlled isis.…

Copyright © 2018 Top News Theme. Theme by MVP Themes, powered by Wordpress.

Neolithic Orkney rivalries detailed in new study
Quarter of 14-year-old girls ‘have signs of depression’
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok